# |
Name |
|
Stock Price |
Change |
Price (30 days) | 52W low/high | Sector |
---|
The Clinical Trials company in Sweden with the highest Total Assets is Swedish Orphan Biovitrum AB (publ) (Stockholm Stock Exchange: SOBI.ST) at USD 6.79 B.
The Clinical Trials company in Sweden with the lowest Total Assets is CellaVision AB (publ) (Stockholm Stock Exchange: CEVI.ST) at None.
The top 10 Clinical Trials companies in Sweden by Total Assets are Swedish Orphan Biovitrum AB (publ), Elekta AB (publ), Vitrolife AB (publ), Arjo AB (publ), Vimian Group AB (publ), Surgical Science Sweden AB (publ), Camurus AB (publ), Xvivo Perfusion AB (publ), RaySearch Laboratories AB (publ) and Magle Chemoswed Holding AB (publ).
The bottom 10 Clinical Trials companies in Sweden by Total Assets are CellaVision AB (publ), BrainCool AB (publ), Cantargia AB (publ), BioInvent International AB (publ), Alzinova AB (publ), BioArctic AB (publ), Aptahem AB (publ), AlzeCure Pharma AB (publ), Ascelia Pharma AB (publ) and Corline Biomedical AB.